228 related articles for article (PubMed ID: 30906877)
1. The management of malignant ascites and impact on quality of life outcomes in women with ovarian cancer.
Meyer L; Suidan R; Sun C; Westin S; Coleman RL; Mills GB
Expert Rev Qual Life Cancer Care; 2016; 1(3):231-238. PubMed ID: 30906877
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic Fluid Drainage: Peritoneovenous Shunt Placement.
Yarmohammadi H; Getrajdman GI
Semin Intervent Radiol; 2017 Dec; 34(4):343-348. PubMed ID: 29249858
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal catheter site metastasis in a patient with advanced ovarian cancer.
Ramirez I; Bansal N; Hoffman M
Am J Hosp Palliat Care; 2012 May; 29(3):241-2. PubMed ID: 21606122
[TBL] [Abstract][Full Text] [Related]
4. [Pathogenesis and management of refractory malignant ascites].
Saâda E; Follana P; Peyrade F; Mari V; François E
Bull Cancer; 2011 Jun; 98(6):679-87. PubMed ID: 21636346
[TBL] [Abstract][Full Text] [Related]
5. Palliation of malignant ascites.
Hodge C; Badgwell BD
J Surg Oncol; 2019 Jul; 120(1):67-73. PubMed ID: 30903617
[TBL] [Abstract][Full Text] [Related]
6. Malignant ascites in ovarian cancer and the role of targeted therapeutics.
Smolle E; Taucher V; Haybaeck J
Anticancer Res; 2014 Apr; 34(4):1553-61. PubMed ID: 24692682
[TBL] [Abstract][Full Text] [Related]
7. Management of malignant ascites with peritoneovenous shunting.
Reinhold RB; Lokich JJ; Tomashefski J; Costello P
Am J Surg; 1983 Apr; 145(4):455-7. PubMed ID: 6837881
[TBL] [Abstract][Full Text] [Related]
8. Malignant ascites: systematic review and guideline for treatment.
Becker G; Galandi D; Blum HE
Eur J Cancer; 2006 Mar; 42(5):589-97. PubMed ID: 16434188
[TBL] [Abstract][Full Text] [Related]
9. Permanent catheters for recurrent ascites-a critical and systematic review of study methodology.
Christensen L; Wildgaard L; Wildgaard K
Support Care Cancer; 2016 Jun; 24(6):2767-79. PubMed ID: 26928443
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer.
Hamilton CA; Maxwell GL; Chernofsky MR; Bernstein SA; Farley JH; Rose GS
Gynecol Oncol; 2008 Dec; 111(3):530-2. PubMed ID: 18561992
[TBL] [Abstract][Full Text] [Related]
11. Drainage of malignant ascites: patient selection and perspectives.
Stukan M
Cancer Manag Res; 2017; 9():115-130. PubMed ID: 28442933
[TBL] [Abstract][Full Text] [Related]
12. Management of non-ovarian cancer malignant ascites through indwelling catheter drainage.
Gu X; Zhang Y; Cheng M; Liu M; Zhang Z; Cheng W
BMC Palliat Care; 2016 Apr; 15():44. PubMed ID: 27103467
[TBL] [Abstract][Full Text] [Related]
13. Current and future options in the treatment of malignant ascites in ovarian cancer.
Woopen H; Sehouli J
Anticancer Res; 2009 Aug; 29(8):3353-9. PubMed ID: 19661355
[TBL] [Abstract][Full Text] [Related]
14. Management of symptomatic ascites and post-operative lymphocysts with an easy-to-use, patient-controlled, vascular catheter.
Stukan M; Leśniewski-Kmak K; Wróblewska M; Dudziak M
Gynecol Oncol; 2015 Mar; 136(3):466-71. PubMed ID: 25434633
[TBL] [Abstract][Full Text] [Related]
15. A survey of practice in management of malignant ascites.
Lee CW; Bociek G; Faught W
J Pain Symptom Manage; 1998 Aug; 16(2):96-101. PubMed ID: 9737100
[TBL] [Abstract][Full Text] [Related]
16. Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures.
Sangisetty SL; Miner TJ
World J Gastrointest Surg; 2012 Apr; 4(4):87-95. PubMed ID: 22590662
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal Dialysis Catheters to Treat Refractory Non-Malignant Ascites.
Hingwala J; Whitlock R; Dunsmore S; Armstrong S; Tangri N; Komenda P
Perit Dial Int; 2017; 37(4):481-482. PubMed ID: 28676515
[TBL] [Abstract][Full Text] [Related]
18. Malignant Ascites: Validation of a Novel Ascites Symptom Mini-Scale for Use in Patients With Ovarian Cancer.
Eitan R; Raban O; Tsoref D; Jakobson-Setton A; Sabah G; Salman L; Yeoshua E; Ben-Haroush A
Int J Gynecol Cancer; 2018 Jul; 28(6):1162-1166. PubMed ID: 29664840
[TBL] [Abstract][Full Text] [Related]
19. The current and future management of malignant ascites.
Smith EM; Jayson GC
Clin Oncol (R Coll Radiol); 2003 Apr; 15(2):59-72. PubMed ID: 12708713
[TBL] [Abstract][Full Text] [Related]
20. The use of peritoneal venous shunting for intractable neonatal ascites: a short case series.
Herman R; Kunisaki S; Molitor M; Gadepalli S; Hirschl R; Geiger J
J Pediatr Surg; 2011 Aug; 46(8):1651-4. PubMed ID: 21843738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
